Perbedaan Organon Pharma Indonesia Tbk. dan Soechi Lines Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Soechi Lines Tbk. diperdagangkan di Rp650 (kapitalisasi pasar 4,59 T, volume 24 jam 18,88 jt). Perbedaan utamanya: Soechi Lines Tbk. jauh lebih besar — sekitar 44× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SOCI | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 4,59 T |
Volume | — | 18,88 jt |
Lot | — | 188,83 rb |
Perputaran | — | 12,09 M |
Harga Rata-rata | — | 640,06 |
Nilai Transaksi | — | 12,09 M |
Harga Ekuilibrium Indikatif | — | 650 |
Volume Ekuilibrium Indikatif | — | 1,93 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Soechi Lines Tbk (the Company) was established in Jakarta based on the Notarial Deed No.16 of Meissie Pholuan, S.H., dated August 13, 2010.
Selengkapnya di halaman SOCI →